Recent Posts

Have a contact at Journey Medical and they're pissed that the only reason people are using their product is to get Sofdra. They get an initial prescription and are then reporting to their doctor or dermatologist that Qbrexza doesn't work opening them up to attain Sofdra via their insurer. Apparently the sharp rise in sales is not resulting in repeat client business and Claude Maraoui is not happy. Looks like Sofdra has the upper hand here.

anonymous said:

Heard that Ricks will be replaced after CVS and CVOT debacle

Click to expand...

I blame the FDA for removing the diabetes CV safety trial mandate the same year Mounjaro is launched and Novo for working a better deal.

anonymous said:

NVS loves to add layer upon layer of people who know nothing about the account, needs all the intel from the reps and then takes the credit to justify their job. We’d rather just have the SAMs back, we have no idea what the end game is, but it’s a colossal screw up.

Click to expand...

This! The is the new MPA role in a nutshell.

anonymous said:

Agree with you 100%.

Click to expand...

Hearing the same thing. Payor after more indication, and Lilly is quietly fretting lack of CVOT data.

How’s managment?